INDV — Supernus, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1625297 ·
Last close
$36.28
Market Cap
$4.28B
52W High
$37.01
52W Low
$35.32
ADV30
4,869,435
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 356,000,000 305,000,000 181,000,000 137,000,000 1,332,000,000 305,000,000 1,392,000,000
Jun 2026 343,000,000 293,000,000 159,000,000 122,000,000 1,233,000,000 222,000,000 1,440,000,000
Mar 2026 317,000,000 277,000,000 137,000,000 89,000,000 1,197,000,000 175,000,000 1,341,000,000
Dec 2025 358,000,000 291,000,000 83,000,000 102,000,000 1,201,000,000 195,000,000 1,300,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-41,000,000
Investing CF
$-70,000,000
Financing CF
$-176,000,000
CapEx
$-71,000,000
Dividends Paid
—
Buybacks
$-302,000,000
EPS Diluted TTM
$2.79
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-334,000,000
Inventory
$151,000,000
Receivables
$287,000,000
ST Investments
$0
EBIT TTM
$420,000,000
Pretax Income TTM
$393,000,000
Interest Exp TTM
$27,000,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,374,000,000
EBITDA
$652,000,000
Free Cash Flow
$227,124,992
Enterprise Value
$4,370,907,648
Total Cash
$305,000,000
Total Debt
$501,000,000
Shares Out
118,035,272
Trailing EPS
$2.79
Book Value
$-1.76
ROE
—
ROA
29.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,239,000,000 265,000,000 210,000,000 1,201,000,000 1,300,000,000 -99,000,000 -27,000,000
Dec 2024 1,188,000,000 234,000,000 7,000,000 1,316,000,000 1,653,000,000 -337,000,000 36,000,000
Dec 2023 1,093,000,000 247,000,000 -126,000,000 1,760,000,000 1,952,000,000 -192,000,000 -300,000,000
Dec 2022 901,000,000 215,000,000 -44,000,000 1,769,000,000 1,718,000,000 51,000,000 -4,000,000

TTM Snapshot

Revenues TTM
$1,331,000,000
NetIncome TTM
$356,000,000
OpCashFlow TTM
—
Assets (Latest)
$1,233,000,000
Forward EPS
$4.51

Peers — same industry

TickerNameMarket CapLastDaily %
IONS IONIS PHARMACEUTICALS INC $4.49B $26.96 —
EWTX Edgewise Therapeutics, Inc. $4.60B $42.04 —
KNSA Kiniksa Pharmaceuticals International, plc $4.64B $95.11 —
GIKLY Grifols SA $4.69B $5.55 —
SLS SELLAS Life Sciences Group, Inc. $3.90B $19.15 —

News headlines (Yahoo Finance, 1h cache)

Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Turnaround Narrative
2026-10-30 22:20 · Yahoo
Indivior Pharmaceuticals (INDV) Shareholders Back Merger After Record Third Quarter
2026-10-30 05:15 · Yahoo
Indivior Pharmaceuticals Inc. (INDV) Beats Q3 Earnings and Revenue Estimates
2026-10-29 11:35 · Yahoo
Indivior Reports Third Quarter 2026 Financial Results
2026-10-29 11:00 · Yahoo
Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600
2026-10-28 21:43 · Yahoo
MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600
2026-10-22 22:08 · Yahoo
Indivior to Report Third Quarter 2026 Financial Results
2026-10-19 12:30 · Yahoo
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
2026-09-17 11:00 · Yahoo
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-14 13:30 · Yahoo
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
2026-09-02 15:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.